About Forkhead box protein D1
Forkhead box protein D1 (FOXD1) is a protein
from Homo sapiens identified by UniProt accession
Q16676, 465 residues long.
MolForge cross-references it against 0 known binders and
161 disease associations.
Target properties
| Protein name | Forkhead box protein D1 |
| UniProt accession | Q16676 |
| Gene | FOXD1 |
| Organism | Homo sapiens |
| Length | 465 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (161)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.46
- heel bone mineral density · score 0.38
- body height · score 0.35
- pulse pressure measurement · score 0.34
- bone quantitative ultrasound measurement · score 0.29
- neurofibrillary tangles measurement · score 0.24
- macula measurement · score 0.22
- cardiovascular disease · score 0.21
- delivery measurement · score 0.19
- hereditary breast ovarian cancer syndrome · score 0.12
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q16676-F1 | alphafold | PREDICTED | 56.74 | — |
Amino-acid sequence (465 residues)
MTLSTEMSDA SGLAEETDID VVGEGEDEED EEEEDDDEGG GGGPRLAVPA QRRRRRRSYA GEDELEDLEE EEDDDDILLA PPAGGSPAPP GPAPAAGAGA GGGGGGGGAG GGGSAGSGAK NPLVKPPYSY IALITMAILQ SPKKRLTLSE ICEFISGRFP YYREKFPAWQ NSIRHNLSLN DCFVKIPREP GNPGKGNYWT LDPESADMFD NGSFLRRRKR FKRQPLLPPN AAAAESLLLR GAGAAGGAGD PAAAAALFPP APPPPPHAYG YGPYGCGYGL QLPPYAPPSA LFAAAAAAAA AAAFHPHSPP PPPPPHGAAA ELARTAFGYR PHPLGAALPG PLPASAAKAG GPGASALARS PFSIESIIGG SLGPAAAAAA AAQAAAAAQA SPSPSPVAAP PAPGSSGGGC AAQAAVGPAA ALTRSLVAAA AAAASSVSSS AALGTLHQGT ALSSVENFTA RISNC
Explore Forkhead box protein D1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets